1. Home
  2. LOAN vs ICCC Comparison

LOAN vs ICCC Comparison

Compare LOAN & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.83

Market Cap

51.9M

Sector

Real Estate

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$5.54

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOAN
ICCC
Founded
1989
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.9M
55.5M
IPO Year
1999
1987

Fundamental Metrics

Financial Performance
Metric
LOAN
ICCC
Price
$4.83
$5.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.6K
18.5K
Earning Date
10-24-2025
11-13-2025
Dividend Yield
9.85%
N/A
EPS Growth
N/A
N/A
EPS
0.46
0.26
Revenue
$7,138,128.00
$27,769,304.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
$10.09
$20.34
Revenue Growth
N/A
16.49
52 Week Low
$4.29
$4.19
52 Week High
$6.05
$7.60

Technical Indicators

Market Signals
Indicator
LOAN
ICCC
Relative Strength Index (RSI) 47.18 48.57
Support Level $4.64 $4.72
Resistance Level $4.83 $5.55
Average True Range (ATR) 0.14 0.31
MACD 0.04 0.08
Stochastic Oscillator 82.25 75.64

Price Performance

Historical Comparison
LOAN
ICCC

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: